$AMS
AMERICAN SHARED HOSPITAL SERVICES

2024 Q4 Form 10-Q Financial Statement

#000143774924035251 Filed on November 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $6.999M
YoY Change 36.33%
Cost Of Revenue
YoY Change
Gross Profit $1.370M
YoY Change -34.82%
Gross Profit Margin 19.57%
Selling, General & Admin $1.923M
YoY Change 10.84%
% of Gross Profit 140.36%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.923M
YoY Change 10.84%
Operating Profit -$889.0K
YoY Change -1087.78%
Interest Expense $336.0K
YoY Change 21.3%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$579.0K
YoY Change -357.33%
Income Tax -$169.0K
% Of Pretax Income
Net Earnings -$207.0K
YoY Change -275.42%
Net Earnings / Revenue -2.96%
Basic Earnings Per Share -$0.03
Diluted Earnings Per Share -$0.03
COMMON SHARES
Basic Shares Outstanding 6.420M 6.360M
Diluted Shares Outstanding 6.482M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $13.83M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $8.635M
Other Receivables $1.306M
Total Short-Term Assets $25.72M
YoY Change 26.26%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill $1.265M
YoY Change 0.0%
Intangibles $78.00K
YoY Change 0.0%
Long-Term Investments
YoY Change
Other Assets $394.0K
YoY Change 11.61%
Total Long-Term Assets $37.55M
YoY Change 39.14%
TOTAL ASSETS
Total Short-Term Assets $25.72M
Total Long-Term Assets $37.55M
Total Assets $63.27M
YoY Change 33.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.786M
YoY Change 416.18%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due $3.557M
YoY Change 143.8%
Total Short-Term Liabilities $17.56M
YoY Change 74.75%
LONG-TERM LIABILITIES
Long-Term Debt $10.82M
YoY Change 3.48%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $10.82M
YoY Change 3.48%
TOTAL LIABILITIES
Total Short-Term Liabilities $17.56M
Total Long-Term Liabilities $10.82M
Total Liabilities $31.44M
YoY Change 47.23%
SHAREHOLDERS EQUITY
Retained Earnings $7.143M
YoY Change 122.25%
Common Stock $19.28M
YoY Change 2.03%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $26.42M
YoY Change
Total Liabilities & Shareholders Equity $63.27M
YoY Change 33.6%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$207.0K
YoY Change -275.42%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Registrant Name
EntityRegistrantName
AMERICAN SHARED HOSPITAL SERVICES
dei Entity Central Index Key
EntityCentralIndexKey
0000744825
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
100000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
100000 usd
CY2024Q3 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
156000 usd
CY2023Q4 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
250000 usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2023Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6390000
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6390000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6300000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6300000
CY2024Q3 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
88000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
1314000 usd
CY2024Q3 ams Number Of Medical Centers
NumberOfMedicalCenters
10 pure
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 pure
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-08789
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
CA
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-2918118
dei Entity Address Address Line1
EntityAddressAddressLine1
601 Montgomery Street
dei Entity Address City Or Town
EntityAddressCityOrTown
San Francisco
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94111-2619
dei City Area Code
CityAreaCode
415
dei Local Phone Number
LocalPhoneNumber
788-5300
dei Security12b Title
Security12bTitle
American Shared Hospital Services Common Stock, No Par Value
dei Trading Symbol
TradingSymbol
AMS
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6420000
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13827000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13690000 usd
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
250000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
118000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8635000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4343000 usd
CY2024Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
1306000 usd
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
504000 usd
CY2024Q3 ams Prepaid Maintenance Current
PrepaidMaintenanceCurrent
945000 usd
CY2023Q4 ams Prepaid Maintenance Current
PrepaidMaintenanceCurrent
1275000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
757000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
526000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
25720000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
20456000 usd
CY2024Q3 ams Property Plant And Equipment Net Excluding Land
PropertyPlantAndEquipmentNetExcludingLand
34807000 usd
CY2023Q4 ams Property Plant And Equipment Net Excluding Land
PropertyPlantAndEquipmentNetExcludingLand
25844000 usd
CY2024Q3 us-gaap Land
Land
19000 usd
CY2023Q4 us-gaap Land
Land
19000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
1265000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
1265000 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
78000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
78000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
986000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
57000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
394000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
443000 usd
CY2024Q3 us-gaap Assets
Assets
63269000 usd
CY2023Q4 us-gaap Assets
Assets
48162000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1786000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
315000 usd
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1223000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
757000 usd
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1966000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1226000 usd
CY2024Q3 ams Asset Retirement Obligation Related Party Current
AssetRetirementObligationRelatedPartyCurrent
750000 usd
CY2023Q4 ams Asset Retirement Obligation Related Party Current
AssetRetirementObligationRelatedPartyCurrent
650000 usd
CY2024Q3 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
0 usd
CY2023Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
1229000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
235000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
57000 usd
CY2024Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
4500000 usd
CY2023Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
2500000 usd
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
3557000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2084000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
17561000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10779000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1500000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
10818000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
11041000 usd
CY2024Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1560000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
63000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
31439000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
21883000 usd
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
10763000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
10763000 usd
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
8517000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
8232000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
7143000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
3629000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
26423000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
22624000 usd
CY2024Q3 us-gaap Minority Interest
MinorityInterest
5407000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
3655000 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
31830000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
26279000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
63269000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
48162000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6999000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5134000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19271000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15627000 usd
CY2024Q3 us-gaap Direct Operating Maintenance Supplies Costs
DirectOperatingMaintenanceSuppliesCosts
613000 usd
CY2023Q3 us-gaap Direct Operating Maintenance Supplies Costs
DirectOperatingMaintenanceSuppliesCosts
518000 usd
us-gaap Direct Operating Maintenance Supplies Costs
DirectOperatingMaintenanceSuppliesCosts
1671000 usd
us-gaap Direct Operating Maintenance Supplies Costs
DirectOperatingMaintenanceSuppliesCosts
1509000 usd
CY2024Q3 us-gaap Cost Depreciation Amortization And Depletion
CostDepreciationAmortizationAndDepletion
1666000 usd
CY2023Q3 us-gaap Cost Depreciation Amortization And Depletion
CostDepreciationAmortizationAndDepletion
1228000 usd
us-gaap Cost Depreciation Amortization And Depletion
CostDepreciationAmortizationAndDepletion
4418000 usd
us-gaap Cost Depreciation Amortization And Depletion
CostDepreciationAmortizationAndDepletion
3812000 usd
CY2024Q3 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
3180000 usd
CY2023Q3 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
1095000 usd
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
6691000 usd
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
2997000 usd
CY2024Q3 ams Other Cost Of Operating Revenue Related Party
OtherCostOfOperatingRevenueRelatedParty
170000 usd
CY2023Q3 ams Other Cost Of Operating Revenue Related Party
OtherCostOfOperatingRevenueRelatedParty
191000 usd
ams Other Cost Of Operating Revenue Related Party
OtherCostOfOperatingRevenueRelatedParty
510000 usd
ams Other Cost Of Operating Revenue Related Party
OtherCostOfOperatingRevenueRelatedParty
781000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
1370000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
2102000 usd
us-gaap Gross Profit
GrossProfit
5981000 usd
us-gaap Gross Profit
GrossProfit
6528000 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1923000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1735000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5698000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5262000 usd
CY2024Q3 us-gaap Interest Expense
InterestExpense
336000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
277000 usd
us-gaap Interest Expense
InterestExpense
1070000 usd
us-gaap Interest Expense
InterestExpense
825000 usd
CY2024Q3 ams Write Down Of Impaired Assets And Associated Removal Costs
WriteDownOfImpairedAssetsAndAssociatedRemovalCosts
0 usd
CY2023Q3 ams Write Down Of Impaired Assets And Associated Removal Costs
WriteDownOfImpairedAssetsAndAssociatedRemovalCosts
0 usd
ams Write Down Of Impaired Assets And Associated Removal Costs
WriteDownOfImpairedAssetsAndAssociatedRemovalCosts
188000 usd
ams Write Down Of Impaired Assets And Associated Removal Costs
WriteDownOfImpairedAssetsAndAssociatedRemovalCosts
578000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-889000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
90000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-975000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-137000 usd
CY2024Q3 us-gaap Business Combination Bargain Purchase Gain Recognized Amount
BusinessCombinationBargainPurchaseGainRecognizedAmount
263000 usd
CY2023Q3 us-gaap Business Combination Bargain Purchase Gain Recognized Amount
BusinessCombinationBargainPurchaseGainRecognizedAmount
0 usd
us-gaap Business Combination Bargain Purchase Gain Recognized Amount
BusinessCombinationBargainPurchaseGainRecognizedAmount
3942000 usd
us-gaap Business Combination Bargain Purchase Gain Recognized Amount
BusinessCombinationBargainPurchaseGainRecognizedAmount
0 usd
CY2024Q3 ams Interest And Other Income Loss
InterestAndOtherIncomeLoss
47000 usd
CY2023Q3 ams Interest And Other Income Loss
InterestAndOtherIncomeLoss
135000 usd
ams Interest And Other Income Loss
InterestAndOtherIncomeLoss
212000 usd
ams Interest And Other Income Loss
InterestAndOtherIncomeLoss
318000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-579000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
225000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3179000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
181000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-169000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
60000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-244000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
93000 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-410000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
165000 usd
us-gaap Profit Loss
ProfitLoss
3423000 usd
us-gaap Profit Loss
ProfitLoss
88000 usd
CY2024Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-203000 usd
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
47000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-91000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-107000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-207000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
118000 usd
us-gaap Net Income Loss
NetIncomeLoss
3514000 usd
us-gaap Net Income Loss
NetIncomeLoss
195000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.54
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.54
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6482000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6366000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6482000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6336000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6482000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6432000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6520000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6406000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
25625000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
96000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
100000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
25821000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
97000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-177000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
25741000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
98000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
165000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
26004000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
26279000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
98000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2024Q1 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
38000 usd
CY2024Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
95000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
65000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
26385000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
99000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2024Q2 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
2100000 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
3768000 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
32352000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
88000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2024Q3 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
200000 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-410000 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
31830000 usd
us-gaap Profit Loss
ProfitLoss
3423000 usd
us-gaap Profit Loss
ProfitLoss
88000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4501000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3874000 usd
ams Write Down Of Impaired Assets And Associated Removal Costs
WriteDownOfImpairedAssetsAndAssociatedRemovalCosts
188000 usd
ams Write Down Of Impaired Assets And Associated Removal Costs
WriteDownOfImpairedAssetsAndAssociatedRemovalCosts
578000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
77000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
44000 usd
us-gaap Business Combination Bargain Purchase Gain Recognized Amount
BusinessCombinationBargainPurchaseGainRecognizedAmount
3942000 usd
us-gaap Business Combination Bargain Purchase Gain Recognized Amount
BusinessCombinationBargainPurchaseGainRecognizedAmount
-0 usd
ams Noncash Lease Expense
NoncashLeaseExpense
219000 usd
ams Noncash Lease Expense
NoncashLeaseExpense
231000 usd
ams Unfavorable Lease Position
UnfavorableLeasePosition
26000 usd
ams Unfavorable Lease Position
UnfavorableLeasePosition
usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
183000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
285000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
291000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3975000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
498000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-148000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-799000 usd
ams Increase Decrease In Asset Retirement Obligations Related Party
IncreaseDecreaseInAssetRetirementObligationsRelatedParty
-113000 usd
ams Increase Decrease In Asset Retirement Obligations Related Party
IncreaseDecreaseInAssetRetirementObligationsRelatedParty
578000 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-2006000 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
2291000 usd
ams Increase Decrease In Accounts Payable Accrued Liabilities And Deferred Revenue
IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue
2379000 usd
ams Increase Decrease In Accounts Payable Accrued Liabilities And Deferred Revenue
IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue
713000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-1229000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
54000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-219000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-265000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-107000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8778000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-538000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3278000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6176000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2740000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6176000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1430000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1589000 usd
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
8900000 usd
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
-0 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
10900000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
1400000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
2700000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
usd
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
-0 usd
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
202000 usd
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
38000 usd
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
0 usd
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
95000 usd
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
-0 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
97000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
9000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3116000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-400000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
269000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2202000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13808000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
12453000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14077000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14655000 usd
us-gaap Interest Paid Net
InterestPaidNet
993000 usd
us-gaap Interest Paid Net
InterestPaidNet
781000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1718000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
277000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3114000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 usd
us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
1900000 usd
us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
0 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13827000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14537000 usd
CY2024Q3 us-gaap Restricted Cash
RestrictedCash
250000 usd
CY2023Q3 us-gaap Restricted Cash
RestrictedCash
118000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14077000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14655000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 pure
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6999000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5134000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19271000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15627000 usd
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1644000 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1265000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4501000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3874000 usd
CY2024Q3 us-gaap Interest Expense
InterestExpense
336000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
277000 usd
us-gaap Interest Expense
InterestExpense
1070000 usd
us-gaap Interest Expense
InterestExpense
825000 usd
CY2024Q3 us-gaap Interest Income Interest Earning Asset
InterestIncomeInterestEarningAsset
63000 usd
CY2023Q3 us-gaap Interest Income Interest Earning Asset
InterestIncomeInterestEarningAsset
149000 usd
us-gaap Interest Income Interest Earning Asset
InterestIncomeInterestEarningAsset
252000 usd
us-gaap Interest Income Interest Earning Asset
InterestIncomeInterestEarningAsset
346000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-169000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
60000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-244000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
93000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-207000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
118000 usd
us-gaap Net Income Loss
NetIncomeLoss
3514000 usd
us-gaap Net Income Loss
NetIncomeLoss
195000 usd
CY2024Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
80692000 usd
CY2023Q4 ams Property Plant And Equipment Gross Excluding Land
PropertyPlantAndEquipmentGrossExcludingLand
81227000 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
45885000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
55383000 usd
CY2024Q3 ams Property Plant And Equipment Net Excluding Land
PropertyPlantAndEquipmentNetExcludingLand
34807000 usd
CY2023Q4 ams Property Plant And Equipment Net Excluding Land
PropertyPlantAndEquipmentNetExcludingLand
25844000 usd
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1644000 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1265000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4501000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3874000 usd
CY2024Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
19000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
77000 usd
CY2023Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
7000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
44000 usd
CY2024Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
184000 usd
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
164000 usd
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
14375000 usd
CY2024Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
184000 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
727000 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
3402000 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
8272000 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
1033000 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
540000 usd
CY2024Q3 ams Longterm Debt Maturity Thereafter
LongtermDebtMaturityThereafter
585000 usd
CY2024Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
14559000 usd
CY2024Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
254000 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
472000 usd
CY2024Q3 ams Accrued Operating Costs Current
AccruedOperatingCostsCurrent
943000 usd
CY2023Q4 ams Accrued Operating Costs Current
AccruedOperatingCostsCurrent
450000 usd
CY2024Q3 ams Accrued Liabilites Other Current
AccruedLiabilitesOtherCurrent
769000 usd
CY2023Q4 ams Accrued Liabilites Other Current
AccruedLiabilitesOtherCurrent
304000 usd
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1966000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1226000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
986000 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1735000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
109000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
346000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
347000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
347000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
348000 usd
CY2024Q3 ams Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
958000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2455000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
720000 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1735000 usd
CY2024Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
133000 usd
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
59000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
219000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
265000 usd
CY2024Q3 us-gaap Lease Cost
LeaseCost
118000 usd
CY2023Q3 us-gaap Lease Cost
LeaseCost
29000 usd
us-gaap Lease Cost
LeaseCost
195000 usd
us-gaap Lease Cost
LeaseCost
136000 usd
CY2024Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
133000 usd
CY2023Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
59000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
219000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
265000 usd
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y10M6D
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y10M20D
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y10M6D
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y10M20D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.08 pure
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0499 pure
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.08 pure
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0499 pure
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-207000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
118000 usd
us-gaap Net Income Loss
NetIncomeLoss
3514000 usd
us-gaap Net Income Loss
NetIncomeLoss
195000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6482000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6366000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6482000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6336000
CY2024Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
66000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
38000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
70000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6482000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6432000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6520000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6406000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.54
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.54
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2024Q3 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
88000 usd
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
285000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
98000 usd
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
291000 usd
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
26000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
146000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.83
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y5M8D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
84000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.87
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
62000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.76
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y6M21D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
20000 usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
35000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.76
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
95000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.76
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y9M29D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
25000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
70000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.82
ams Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm
P7Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
19000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.69
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
146000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.8
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y6M3D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
38000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.86
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y4M6D

Files In Submission

Name View Source Status
ams-20240930_cal.xml Edgar Link unprocessable
0001437749-24-035251-index-headers.html Edgar Link pending
0001437749-24-035251-index.html Edgar Link pending
0001437749-24-035251.txt Edgar Link pending
0001437749-24-035251-xbrl.zip Edgar Link pending
ams-20240930.xsd Edgar Link pending
asha20240930_10q.htm Edgar Link pending
ex_715868.htm Edgar Link pending
ex_715869.htm Edgar Link pending
ex_715870.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
ams-20240930_def.xml Edgar Link unprocessable
ams-20240930_lab.xml Edgar Link unprocessable
ams-20240930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
asha20240930_10q_htm.xml Edgar Link completed
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending